# Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs

> **NCT02532907** · — · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 5 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **PROCEDURE:** Liver Biopsy

## Key facts

- **NCT ID:** NCT02532907
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2018-07-10
- **Final completion:** 2018-07-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532907, "Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02532907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*